3 Stocks I Saw on T...
C.R. Bard Inc. (BCR: NYSE)
$95.46 -0.14 | -0.15%
06/04/12 - 04:00 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 2.90B | 2.72B | 2.53B | 2.45B |
| Cost of Sales | 982.20M | 915.10M | 865.50M | 861.20M |
| Gross Operating Profit | 1.91B | 1.81B | 1.67B | 1.59B |
| Selling, General, and Administrative Expenses | 1.04B | 759.80M | 682.50M | 709.50M |
| Research & Development | 185.40M | 185.40M | 179.60M | 199.10M |
| Operating Income before D & A (EBITDA) | 687.70M | 859.90M | 807.30M | 682.30M |
| Depreciation & Amortization | 115.10M | 104.90M | 93.50M | 90.90M |
| Interest Income | 3.50M | 0.00 | 0.00 | 0.00 |
| Other Income - Net | -5.20M | -20.90M | -30.50M | -29.40M |
| Special Income / Charges | -11.50M | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | 547.20M | 734.10M | 683.30M | 562.00M |
| Interest Expense | 36.40M | 16.40M | 11.80M | 12.10M |
| Pre-Tax Income | 510.80M | 717.70M | 671.50M | 549.90M |
| Income Taxes | 182.80M | 208.10M | 210.10M | 133.40M |
| Minority Interest | 0.00 | 400.00K | 1.30M | 0.00 |
| Net Income From Continuing Operations | 328.00M | 509.20M | 460.10M | 416.50M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | 328.00M | 509.20M | 460.10M | 416.50M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 328.00M | 509.20M | 460.10M | 416.50M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
351.70M | 509.20M | 460.10M | 416.50M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 328.00M | 509.20M | 460.10M | 416.50M |
| Basic EPS from Continuing Ops. | 3.75 | 5.39 | 4.66 | 4.19 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | 3.75 | 5.39 | 4.66 | 4.19 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | 3.75 | 5.39 | 4.66 | 4.19 |
| Basic Normalized Net Income/Share | 4.02 | 5.39 | 4.66 | 4.19 |
| EPS fr Continuing Ops. | 3.69 | 5.32 | 4.60 | 4.06 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | 3.69 | 5.32 | 4.60 | 4.06 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | 3.69 | 5.32 | 4.60 | 4.06 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
3.96 | 5.32 | 4.60 | 4.06 |
| Dividends Paid per Share | 0.74 | 0.70 | 0.66 | 0.62 |
Portfolios with BCR
- Portfolio NameUser Type
- Contributor18 Dividend Stocks That Wil...
- Contributor10 Best 'Dividend Aristocra...
- ProDonald Yacktman - Yacktman ...
- Contributor12 Stocks for a Diverse Mon...
- ProAl Gore - Generation Invest...
- UserLes's Picks
- ContributorThe 2011 Dividend Aristocrats
- ContributorDividend Stocks for the Wee...
- ContributorDefensive Stock Short-Squee...
- ContributorTop Health Care Stocks for ...
Latest BCR Headlines from TheStreet
- C.R. Bard Stock To Go Ex-dividend Tomorrow (BCR) 04.25.12 | 09:04 am
- CR Bard's CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.25.12 | 12:04 am
- C.R. Bard Rises On Unusually High Volume (BCR) 02.10.12 | 04:02 pm
- 10 Best 'Dividend Aristocrats' for 2012 02.01.12 | 07:02 am
- CR Bard's CEO Discusses Q4 2011 Results - Earnings Call Transcript 01.31.12 | 11:01 pm
- C.R. Bard Stock To Go Ex-dividend Tomorrow (BCR) 01.18.12 | 09:01 am
- 5 Ex-Dividend Stocks With Buy Ratings 01.18.12 | 08:01 am
- CR Bard Inc., 2012 Guidance/Update Call, Dec 20, 2011 12.21.11 | 12:12 am
- CR Bard's CEO Hosts Annual Analyst Meeting - Event Transcript 12.21.11 | 12:12 am
- Analysts' Actions: GRPN, VRUS, MU, CVC 12.19.11 | 09:12 am
Press Releases for BCR
- Bard Names Christopher S. Holland Senior Vice President And Chief Financial Officer - Business Wire 04.30.12 | 04:04 pm
- Bard Announces First Quarter Results - Business Wire 04.24.12 | 04:04 pm
- Bard To Host Earnings Conference Call On April 24, 2012 - Business Wire 04.17.12 | 01:04 pm
- Bard Announces Fourth Quarter Results - Business Wire 01.31.12 | 04:01 pm
- Bard To Host Earnings Conference Call On January 31, 2012 - Business Wire 01.24.12 | 10:01 am
- Bard Acquires Lutonix, Inc. - Business Wire 12.20.11 | 04:12 pm
- Bard Declares Quarterly Dividend - Business Wire 12.14.11 | 04:12 pm
- Bard To Host December 2011 Investor Conference - Business Wire 11.03.11 | 01:11 pm
- Bard Announces Agreement To Acquire Medivance, Inc. - Business Wire 10.25.11 | 04:10 pm
- Bard Announces Third Quarter Results - Business Wire 10.25.11 | 04:10 pm
Partner Headlines for BCR
- COV Launches Endo GIA Radial Reload - Analyst Blog - Zacks 06.01.12 | 05:06 pm
- Covidien Prices Senior Notes - Analyst Blog - Zacks 05.25.12 | 04:05 pm
- The Zacks Analyst Blog Highlights: AngioDynamics, J.P. Morgan, Bank of America, KeyCorp and CR Bard - Press Releases - Zacks 05.24.12 | 09:05 am
- The Zacks Analyst Blog Highlights: Covidien, General Electrical, Becton, Dickinson and Company, Johnson and Johnson and CR Bard - Press Releases - Zacks 05.14.12 | 09:05 am
- Find Outperforming Stocks in a Down Market! - Press Releases - Zacks 05.11.12 | 09:05 am
- Find Outperforming Stocks in a Down Market! - Investment Ideas - Zacks 05.11.12 | 01:05 am
- Covidien to Acquire Oridion Systems - Analyst Blog - Zacks 04.13.12 | 04:04 pm
- ANGO Mixed, Adjusts View - Analyst Blog - Zacks 04.05.12 | 09:04 am
- Covidien Takes Over superDimension - Analyst Blog - Zacks 04.03.12 | 09:04 am
- The Zacks Analyst Blog Highlights: Applied Materials, Covidien, Johnson & Johnson, Becton Dickinson and C.R. Bard - Press Releases - Zacks 03.08.12 | 09:03 am





